跳至主要内容
临床试验/TCTR20230913006
TCTR20230913006已完成2 期

The clinical efficacy of Japanese Cayratia Herb combined with mesalazine in the treatment of ulcerative colitis: a randomized controlled clinical trial

ijiang Ji0 个研究点目标入组 94 人开始时间: 2023年9月13日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • (1) Meet the above diagnostic criteria and syndrome differentiation criteria;
  • (2) No history of diarrhea or other gastrointestinal diseases in the past 4 weeks;
  • (3) No antibiotics and microecologics in the past 1 month;
  • (4) Patients voluntarily joined this study and signed informed consent.

排除标准

  • (1) Combined with severe complications of UC, such as local stenosis, intestinal obstruction, intestinal perforation, rectal rest, toxic colon dilatation, colon cancer, rectal cancer and anal disease;
  • (2) Pregnant or preparing for pregnancy, lactating women;
  • (3) Allergic constitution and multiple drug allergies;
  • (4) Combined with liver, kidney, hematopoietic system, endocrine system and other serious diseases and malignant tumors;
  • (5) Researchers who have participated in or are participating in other trials within the past 1 month;
  • (6) Patients with mental disorders.

研究者

发起方
ijiang Ji

相似试验